Associate Professor Tamar Mendelson, PhD, an expert in adolescent mental health at the Johns Hopkins Bloomberg School of Public Health, has been appointed as a Bloomberg Professor of American Health.

Scientists at Johns Hopkins Bloomberg School of Public Health have developed a powerful method for characterizing the broad patterns of genetic contributions to traits and diseases.

Older kidney disease patients who are sick enough to require the blood-filtering treatment known as dialysis are at high risk of dementia, including Alzheimer’s disease, according to a study.

“Safe consumption sites,” where people can use pre-obtained drugs with medically trained personnel on hand to treat overdoses, garner higher public support when they are called “overdose prevention sites,” according to a study.

Microorganisms in colder climates darken themselves to capture more heat from the sun and improve their ability to survive, according to a study from scientists at Johns Hopkins Bloomberg School of Public Health.

A team led by scientists from the Johns Hopkins Bloomberg School of Public Health has sequenced and annotated the first complete mitochondrial genome of Anopheles funestus, one of the main vectors of malaria in sub-Saharan Africa.

A majority of registered voters oppose recent efforts to scale back Supplemental Nutrition Assistance Program (SNAP) food benefits and believe the government should be doing more to meet the needs of people facing food insecurity and other challenges,

Men may recover more quickly from influenza infections because they produce more of a key lung-healing protein, a study from scientists at Johns Hopkins Bloomberg School of Public Health suggests.

Advanced algorithms working from large chemical databases can predict a new chemical’s toxicity better than standard animal tests, suggests a study led by scientists at Johns Hopkins Bloomberg School of Public Health.

1/3 of children in the U.S. receive recommended screenings designed to catch developmental delays. Findings reveal wide variations in rates, w/ as few as %17 of children under age 3 receiving developmental screening in the lowest performing state.